✦ LIBER ✦

Copp chemotherapy for elderly patients with intermediate and high grade non-Hodgkin's lymphoma

✍ Scribed by Dr Raymond Liang; David Todd; T. K. Chan; Edmond Chiu; Albert Lie; Faith Ho

Publisher: John Wiley and Sons
Year: 1993
Tongue: English
Weight: 479 KB
Volume: 11
Category: Article
ISSN: 0278-0232
DOI: 10.1002/hon.2900110106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An alternating chemotherapy combination

An alternating chemotherapy combination (macoble) for intermediate and high-grade non-hodgkin's lymphoma

✍ M. Harding; L. McNulty; J. Paul; F. Lee; D. Dunlop; M. Soukop 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 485 KB 👁 1 views

48 patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL) received a CHOP based combination with the addition of etoposide on days 1 and 2, bleomycin days 1 and 10 and methotrexate 1.5 g/m2 on day 10 (MACOBLE). Their median age was 59 years, 20 (42 per cent) had an ECOG performance s

Alternating chemotherapy regimen (P-VABE

Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly

✍ Dr. F. Caracciolo; M. Petrini; E. Capochiani; F. Papineschi; G. Carulli; B. Gras 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB 👁 1 views

An intensive third generation regimen (P-VABEC) including adriamycin, etoposide, cyclophosphamide. vincristine, bleomycin and prednisolone was administered to 43 unselected elderly patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL). The median age was 67, 40 per cent were Ann Arb

Long-term follow-up of patients receivin

Long-term follow-up of patients receiving salvage chemotherapy for intermediate and high grade non-Hodgkin's lymphomas

✍ Dr. Raymond H. S. Liang; Edmond K. W. Chiu; T. K. Chan; David Todd; Ronald P. Ng 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 423 KB 👁 1 views

This is an analysis of the long-term follow-up data of 99 patients receiving HOAP-Bleo, IMVP-16 and PAC as salvage chemotherapy for refractory or relapsed intermediate or high grade non-Hodgkin's lymphomas. Most of the patients received HOAP-Bleo or PAC following failure of initial chemotherapy and

Alternating non-cross-resistant chemothe

Alternating non-cross-resistant chemotherapy for non-Hodgkin's lymphoma of intermediate-grade and high-grade malignancy. A pilot study

✍ Masatni Hirano; Masataka Okamoto; Fumio Maruyama; Kohji Ezaki; Kazuyuki Shimizu; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

A brief-duration combination chemotherap

A brief-duration combination chemotherapy for elderly patients with poor-prognosis non-Hodgkin's lymphoma

✍ Mary L. McMaster; David H. Johnson; John P. Greer; Steven N. Wolff; Craig R. Hil 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

Progressive loss of vision in patients w

Progressive loss of vision in patients with high-grade non-Hodgkin's lymphoma

✍ Harald Holte; Gunnar Saeter; Inger Marie S. Dahl; Arne Foss Abrahamsen 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB 👁 2 views